Does ambulatory oxygen improve quality of life in patients with fibrotic lung disease? Results from the AmbOx trial

The AmbOx trial provides RCT evidence for ambulatory oxygen therapy improving HRQoL in patients with fibrotic ILD http://ow.ly/uHC030nEzsz

Detalles Bibliográficos
Autores principales: Creamer, Andrew W., Barratt, Shaney L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2019
Materias:
Expert Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544787/
https://www.ncbi.nlm.nih.gov/pubmed/31191728
http://dx.doi.org/10.1183/20734735.0002-2019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544787/
https://www.ncbi.nlm.nih.gov/pubmed/31191728
http://dx.doi.org/10.1183/20734735.0002-2019

Ejemplares similares